Respiratory Flashcards

1
Q

different stages of acute asthma

A

moderate - PEFR 50-75% of predicted, RR<25, BPM <110

severe - PEFR 33-50%, cant complete sentences, RR>25, BPM >110

life-threatening - <33%, sats <92%, silent chest, cyanosis, bradycardia, dysrhythmia, hypotension, exhaustion, confusion, coma

normal PCO2 = exhaustion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

management of acute asthma

A

admit

oxygen if hypoxaemic - 15L if acutely unwell then downtitrate to flow rate which maintains 94-98%

SABA - inhaled, nebulised

corticosteroid - 40-50mg pred PO 5 day

ipratropium bromide (SAMA)

IV magnesium sulphate

IV aminophylline

ITU/HDU - intubation and ventilation, ECMO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

discharge critera for patients admitted with acute asthma

A

stable on discharge meds for 12-24h
inhaler technique checked and recorded
PEFR >75% best or predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

features of acute bronchitis

A

clinical diagnosis

sx - cough, sore throat, rhinorrhea, wheeze, low grade fever

no other focal chest signs other than wheeze, no real systemic features (whereas pneumonia has systemic features)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

overview of acute bronchitis

A

self limiting chest infection lasting 3w (viral) due to inflammation of trachea + major bronchi - assx with oedematous large airways and sputum production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

management of acute bronchitis

A

CRP testing may be used to guide whether abx therapy is needed

analgesia
good fluid intake
abx if - very unwell, pre-existing co-morbidities, CRP 20-100 (delayed script), CRP >100 (immediate abx)

doxycycline

amoxicillin in children/pregnant women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

infective causes of COPD exacerbations

A

bacteria - haemophilus influenza, streptococcus pneumoniae, moraxella catarrhalis

respiratory virus - 30% exacerbations - human rhinovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

features of COPD exacerbations

A

dyspnoea, cough, wheeze

increase in sputum suggestive of an infective cause

patients may be hypoxic and in some cases have acute confusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

management of COPD exacerbations

A

frequent bronchodilator use + nebuliser
prednisolone 30mg 5 days

oral abx if purulent sputum or clinical signs of pneumonia (amoxicillin, clari, doxy)

admission if adverse criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

inpatient management of COPD exacerbations

A

oxygen - hypercapnia risk therefore target 88-92 with 28% venturi at 4l/min, adjust to 94-98 if pCO2 normal

nebulised bronchodilator - beta-adrenergic agonist (salbutamol), muscarinic antagonists (ipatroprium)

IV hydrocortisone if needed

IV theophylline - if pt not responding to nebulised bronchodilators

NIV - if resp acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

overview of ARDS

A

due to increased permeability of alveolar capillaries causing fluid accumulation in alveoli - significant morbidity, 40% mortality

acute onset and severe
dyspnoea
elevated respiratory rate
bilateral lung crackles
low oxygen saturations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

causes of ARDS

A

infection: sepsis, pneumonia
massive blood transfusion
trauma
smoke inhalation
acute pancreatitis
Covid-19
cardio-pulmonary bypass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

criteria for ARDS

A

acute onset (<1w risk factor)
pulmonary edema - bilateral infiltrates on CXR
non cardiogenic
pO2 <40kPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

management of ARDS

A

ITU mx

oxygenation for hypoxaemia
organ support e..g, vasopressors

tx underlying cause - abs for sepsis

prone position , muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

features of allergic bronchopulmonary aspergillosis

A

allergy to aspegillus spores

causes proximal bronchiectasis and bronchoconstriction (wheeze, cough, dyspnoea)

hx eosinophilia, bronchiectasis
may have previosu hs asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CXR features of allergic bronchopulmonary aspergillosis

A

eosinophilia
flitting CXR changes - ring shadow, tram track opacities shows bronchiectasis
positive radioallergosorbent (RAST) test to Aspergillus
positive IgG precipitins (not as positive as in aspergilloma)
raised IgE

17
Q

management of allergic bronchopulmonary aspergillosis

A

oral glucocorticoids
itraconazole

18
Q

overview of alpha-1 antitrypsin deficiency

A

AR inherited condition Chr14
lack of protease inhibitor (A1AT) which is normally produced by the liver - this protects cells from enzymes such as neutrophil elastase

causes emphysema in young, non smokers

19
Q

features of alpha 1 antitrypsin deficiency

A

lower lobe panacinar emphysema

cirrhosis and HCC in adults, cholestasis in children

test A1AT concentration
obstructive spirometry

20
Q

management of alpha 1 antitrypsin deficiency

A

no smoking
bronchodilators
physiotherapy
IV A1AT protein concentrates
lung volume reduction surgery, lung transplantation

21
Q

risk factors for aspiration pneumonia

A

Poor dental hygiene
Swallowing difficulties
Prolonged hospitalization or surgical procedures
Impaired consciousness
Impaired mucociliary clearance

22
Q

features of aspiration pneumonia

A

affects right middle and lower lobes
can be aerobic or anaerobic bacteria

23
Q

main symptoms of asthma

A

cough - worse at night
dyspnoea
wheeze
chest tightness

expiratory wheeze
reduced PEFR

24
Q

asthma management guidelines

A

SABA
SABA + ICS (low dose - <400mcg budesonide or eq)
SABA + ICS + LRTA
SABA + ICS + LABA (+LRTA depending on pt response)
SABA + LTRA + MART (med-dose ICS 400-800 budesonide or eq)

SABA + LTRA + high dose ICS >800mg/additional drug e.g., theophylline

24
Q

drugs used in asthma management

A

SABA - salbutamol - relaxes smooth muscle of airways

ICS - beclomethasone

LABA - salmeterol

LRTA - montelukast

MART - ICS + LABA

25
Q

investigation findings in asthma

A

spirometry
reduced FEV1
normal FVC
FEV1 <70%

FeNO
nitric oxide levels correlate with level of inflammation

CXR

26
Q

stepping down asthma treatment

A

step down every 3m

reduce inhaled steroids by 25-50% at a time

27
Q

features of atelectasis

A

postop complication
basal alveolar collapse - can lead to respiratory difficulty

dyspnoea and hypoxaemia ~72h postop

position pt upright and do chest physio

28
Q
A
29
Q
A
30
Q
A
31
Q
A
32
Q
A
32
Q
A
33
Q
A